Fri, Apr 18, 2014, 1:44 PM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • fudfighter4 fudfighter4 Feb 4, 2013 11:48 AM Flag

    Fortune favours the brave - but rarely the gullible

    Continually averaging down in a biotech is the right strategy - if you've found the right biotech.

    From the Genta board a few years ago -

    "Time to buy?

    Good to average down, especially at these prices,but I suspect lower.
    I bought last @7.19, hoping for a trade and a rally,GNTA really never saw it.
    Is our bear market rally over? Friday suggested it might be, if volume confirms this week, then have cash to buy this gem.
    Still a news driven biotech, there is always chance of a quick bubble to make money also but I stand by my... buy it, tuck it away, don't look!,come back in 2 years
    Good Luck to all Longs"

    and -

    "The stratagy works because it is after the fear,the shorts and the ride on the biotech rollercoaster.(NDA,FDA etc)

    Analysts ability to "move" a stock will be overtaken by what will be the marketplace in 2 years.(look at post 70's bear market for historical perspective) A marketplace of valuations and earnings.
    GNTA IMHO will have them....soooooooooo But it tuck it away dont'LOOK !come back in 2 years
    Good Luck to all LOngs"

    Genta gained 50% on Friday - from $0.0002 to $0.0003. Let's hope Terry took full advantage of his latest opportunity to average down, by snapping up an extra million shares for $200.

    When a leading contender for the title of Worst Investor in Biotech offers the following warning about INSM -

    "YTD 25% "the short since 7.81......next stop $4"

    - let his track record speak for itself.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
13.41+0.88(+7.02%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
WisdomTree Investments, Inc.
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT